RealTime Dynamix™: Hyperkalemia, June 2016
The sixth monthly update on the launch of Veltassa and the evolution of the Hyperkalemia market provided by 101 Nephrologists.
About Spherix Global Insights
Spherix Global Insights is a newly established business intelligence and market research company headquartered in Cambridge, MA with EU offices in Zug, Switzerland. We specialize in renal, autoimmune, neurologic and rare disease markets.
For more information contact:
Telephone: (800) 661-0571
Email: info@spherixglobalinsights.com
www.spherixglobalinsights.com